Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Card Comparison Method Will Be Developed By Consortium, CMS

Executive Summary

A drug price comparison methodology for the Medicare Rx discount card program will be developed jointly by CMS and an "administrative consortium" of card sponsors under the final drug card rule

You may also be interested in...



Medicare Rx Discount Card Blocked By Court; Industry Programs Continue

A federal court decision blocking the Bush Administration's Medicare-endorsed prescription drug discount card proposal underscores the importance of ongoing industry-based card programs

Medicare Rx Discount Card Blocked By Court; Industry Programs Continue

A federal court decision blocking the Bush Administration's Medicare-endorsed prescription drug discount card proposal underscores the importance of ongoing industry-based card programs

Medicare Rx Card Sponsors Must Disclose Rebate Info Under Final Rule

Medicare Rx discount card sponsors must disclose the total rebates they expect to receive from manufacturers and the share they will pass on to beneficiaries under CMS' final rule

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040442

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel